Sławomir Dobrzycki

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

Guy De Backer, Piotr Jankowski, Kornelia Kotseva et al. · Atherosclerosis · 2019 · 350 citations · Full text

Cardiovascular Epidemiology, Cardiovascular Disease, Coronary Artery Disease +9

Neutrophil-Gelatinase-Associated Lipocalin and Renal Function after Percutaneous Coronary Interventions

Hanna Bachórzewska-Gajewska, E. Sitniewska, Sławomir Dobrzycki · American Journal of Nephrology · 2006 · 251 citations

Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failure

Agata Maciejak, Marek Kiliszek, Marcin Michalak et al. · Genome Medicine · 2015 · 135 citations · Full text

Could Neutrophil-Gelatinase-Associated Lipocalin and Cystatin C Predict the Development of Contrast-Induced Nephropathy after Percutaneous Coronary Interventions in Patients with Stable Angina and Normal Serum Creatinine Values?

Hanna Bachórzewska-Gajewska, E. Sitniewska, Krystyna Pawlak et al. · Kidney & Blood Pressure Research · 2007 · 115 citations

Glomerular Disease, Serum Ngal, Cystatin C +22

Neutrophil Gelatinase-Associated Lipocalin Is a New and Sensitive Marker of Kidney Function in Chronic Kidney Disease Patients and Renal Allograft Recipients

Hanna Bachórzewska-Gajewska, Bogusław Poniatowski, Sławomir Dobrzycki et al. · Transplantation Proceedings · 2009 · 93 citations

Inflammation, Glomerular Disease, Sensitive Marker +14